Evaluation of ten California safe routes to school non-infrastructure (SRTS NI) grantees on changing mode of travel to and from school
Objective: Assess effectiveness of California SRTS NI program by examining characteristics of 10 K-8 schools funded in Federal Cycle 3
Methods: Analysis focused on ten schools that differ in geographics and demographics. Mode shift was assessed by analyzing pre and post parent survey data. Telephone interviews were conducted with SRTS program coordinators to understand program successes, barriers, and parents' perceived safety towards walking/biking to school. Environmental diagnosis of land use around schools was conducted to evaluate the potential for active transportation. Effect of programs on safety was analyzed by calculating pre and post pedestrian and bicycle collision rates around schools.
Results: Telephone interviews will reveal factors that enable or hinder the successful implementation of program activities. Evaluation results will reveal the extent of mode shift and whether positive improvements in parental perceived safety of walking and biking to school resulted from the programs.
Conclusion: SRTS NI funding provides opportunities to promote physical activity through increased outreach and education efforts as well as by engaging community stakeholders. This evaluation compares program implementation strategies and impacts on mode shift across California.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Public health or related research
Discuss reasons for choosing the case study approach for evaluating SRTS NI grantees in California Identify successes from the implementation of the SRTS NI program, especially as it relates to pedestrian safety and physical activity
Qualified on the content I am responsible for because: I have experience conducting research and evaluation of community-based programs.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.